Interestingly, RXRα was reported to inhibit radioresistance in the Head and Neck Squamous Cell Carcinoma [35]; however, its explicit role in breast cancer remains largely elusive. This evidence concerns the gene RXRA and head and neck squamous cell carcinoma.